SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CASI Pharmaceuticals, Inc. – ‘20-F’ for 12/31/23 – ‘XML’

On:  Thursday, 3/28/24, at 11:01am ET   ·   For:  12/31/23   ·   Accession #:  1558370-24-4190   ·   File #:  1-41666

Previous ‘20-F’:  ‘20-F’ on 4/26/23 for 12/31/22   ·   Latest ‘20-F’:  This Filing   ·   14 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/28/24  CASI Pharmaceuticals, Inc.        20-F       12/31/23  142:21M                                    Toppan Merrill Bridge/FA

Annual or Annual-Transition Report by a Foreign Non-Canadian Issuer   —   Form 20-F   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual or Annual-Transition Report by a Foreign     HTML   3.52M 
                Non-Canadian Issuer                                              
 2: EX-1.1      Underwriting Agreement or Conflict Minerals Report  HTML   1.36M 
 3: EX-2.1      Plan of Acquisition, Reorganization, Arrangement,   HTML     58K 
                Liquidation or Succession                                        
 4: EX-4.29     Instrument Defining the Rights of Security Holders  HTML    230K 
 5: EX-4.37     Instrument Defining the Rights of Security Holders  HTML   1.10M 
 6: EX-4.38     Instrument Defining the Rights of Security Holders  HTML    321K 
 7: EX-4.39     Instrument Defining the Rights of Security Holders  HTML     56K 
 8: EX-4.40     Instrument Defining the Rights of Security Holders  HTML    336K 
 9: EX-4.41     Instrument Defining the Rights of Security Holders  HTML    315K 
10: EX-4.42     Instrument Defining the Rights of Security Holders  HTML    140K 
11: EX-4.43     Instrument Defining the Rights of Security Holders  HTML    128K 
12: EX-4.44     Instrument Defining the Rights of Security Holders  HTML    121K 
13: EX-4.45     Instrument Defining the Rights of Security Holders  HTML    314K 
14: EX-4.46     Instrument Defining the Rights of Security Holders  HTML     92K 
15: EX-4.47     Instrument Defining the Rights of Security Holders  HTML    122K 
16: EX-4.48     Instrument Defining the Rights of Security Holders  HTML     60K 
17: EX-8.1      Opinion of Counsel re: Tax Matters                  HTML     38K 
21: EX-13.1     Annual or Quarterly Report to Security Holders      HTML     41K 
22: EX-13.2     Annual or Quarterly Report to Security Holders      HTML     41K 
24: EX-97.1     Clawback Policy re: Recovery of Erroneously         HTML     62K 
                Awarded Compensation                                             
18: EX-11.1     Statement re: the Computation of Earnings Per       HTML     67K 
                Share                                                            
19: EX-12.1     Statement re: the Computation of Ratios             HTML     44K 
20: EX-12.2     Statement re: the Computation of Ratios             HTML     44K 
23: EX-15.1     Letter re: Unaudited Interim Financial Info         HTML     38K 
30: R1          Document and Entity Information                     HTML    115K 
31: R2          Consolidated Balance Sheets                         HTML    147K 
32: R3          Consolidated Balance Sheets (Parenthetical)         HTML     50K 
33: R4          Consolidated Statements of Operations and           HTML    185K 
                Comprehensive Loss                                               
34: R5          Consolidated Statements of Stockholders' Equity     HTML     90K 
35: R6          Consolidated Statements of Cash Flows               HTML    188K 
36: R7          Description of Business                             HTML     87K 
37: R8          Summary of Significant Accounting Policies          HTML     96K 
38: R9          Investment in Equity Securities, at Fair Value and  HTML    187K 
                Long-Term Investments                                            
39: R10         Inventories                                         HTML     41K 
40: R11         Leases                                              HTML     89K 
41: R12         Property, Plant and Equipment                       HTML     61K 
42: R13         Intangible Assets                                   HTML    111K 
43: R14         Accrued and Other Current Liabilities, and Other    HTML     76K 
                Liabilities                                                      
44: R15         Short Term Borrowings                               HTML     43K 
45: R16         Notes Payable                                       HTML     45K 
46: R17         Grants                                              HTML     42K 
47: R18         Redeemable Noncontrolling Interest and Long Term    HTML     68K 
                Borrowing                                                        
48: R19         Shareholders' Equity                                HTML     66K 
49: R20         Costs of Revenues                                   HTML     40K 
50: R21         Net Loss Per Share                                  HTML     65K 
51: R22         Employee Benefit Plan                               HTML     42K 
52: R23         Share-Based Compensation                            HTML    182K 
53: R24         Income Taxes                                        HTML    159K 
54: R25         Fair Value Measurements                             HTML    118K 
55: R26         Related Party Transactions                          HTML     48K 
56: R27         Commitments and Contingencies                       HTML     44K 
57: R28         Restricted Net Assets                               HTML     41K 
58: R29         Subsequent Events                                   HTML     41K 
59: R30         Condensed Financial Information of Registrant       HTML    220K 
60: R31         Summary of Significant Accounting Policies          HTML    164K 
                (Policies)                                                       
61: R32         Summary of Significant Accounting Policies          HTML     50K 
                (Tables)                                                         
62: R33         Investment in Equity Securities, at Fair Value and  HTML    170K 
                Long-Term Investments (Tables)                                   
63: R34         Leases (Tables)                                     HTML     88K 
64: R35         Property, Plant and Equipment (Tables)              HTML     57K 
65: R36         Intangible Assets (Tables)                          HTML    111K 
66: R37         Accrued and Other Current Liabilities, and Other    HTML     76K 
                Liabilities (Tables)                                             
67: R38         Redeemable Noncontrolling Interest (Tables)         HTML     61K 
68: R39         Shareholders' Equity (Tables)                       HTML     53K 
69: R40         Net Loss Per Share (Tables)                         HTML     64K 
70: R41         Share-Based Compensation (Tables)                   HTML    180K 
71: R42         Income Taxes (Tables)                               HTML    159K 
72: R43         Fair Value Measurements (Tables)                    HTML    117K 
73: R44         Condensed Financial Information of Registrant       HTML    222K 
                (Tables)                                                         
74: R45         DESCRIPTION OF BUSINESS - Liquidity and Capital     HTML    111K 
                Resources (Details)                                              
75: R46         DESCRIPTION OF BUSINESS - License and Distribution  HTML     51K 
                Agreements (China Resources Pharmaceutical                       
                Commercial Group International Trading Co., Ltd.)                
                (Details)                                                        
76: R47         DESCRIPTION OF BUSINESS - License and Distribution  HTML     50K 
                Agreements (Precision Autoimmune Therapeutics Co.,               
                Ltd) (Details)                                                   
77: R48         DESCRIPTION OF BUSINESS - License and Distribution  HTML     47K 
                Agreements (Juventas Cell Therapy Ltd.) (Details)                
78: R49         DESCRIPTION OF BUSINESS - License and Distribution  HTML     72K 
                Agreements (BioInvent International AB) (Details)                
79: R50         DESCRIPTION OF BUSINESS - License and Distribution  HTML     54K 
                Agreements (Black Belt Therapeutics Limited)                     
                (Details)                                                        
80: R51         DESCRIPTION OF BUSINESS - License and Distribution  HTML     56K 
                Agreements (Cleave Therapeutics, Inc.) (Details)                 
81: R52         DESCRIPTION OF BUSINESS - License and Distribution  HTML     48K 
                Agreements (Pharmathen Global BV) (Details)                      
82: R53         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     41K 
                Consolidation (Details)                                          
83: R54         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     40K 
                Segment Reporting (Details)                                      
84: R55         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash   HTML     47K 
                and Cash Equivalents (Details)                                   
85: R56         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     46K 
                Aggregate Cost And Fair Value (Details)                          
86: R57         Summary of Significant Accounting Policies - Ppe    HTML     48K 
                (Details)                                                        
87: R58         INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND  HTML     66K 
                LONG-TERM INVESTMENTS - Investment in equity                     
                securities, at fair value-MaxCyte Inc. (Details)                 
88: R59         INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND  HTML     94K 
                LONG-TERM INVESTMENTS - Investment in equity                     
                securities, at fair value-BioInvent International                
                AB ordinary shares and warrants (Details)                        
89: R60         INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND  HTML     71K 
                LONG-TERM INVESTMENTS - BioInvent International AB               
                - Summary of Investments (Details)                               
90: R61         INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND  HTML     66K 
                LONG-TERM INVESTMENTS - Summary of Long-term                     
                investments (Details)                                            
91: R62         INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND  HTML     86K 
                LONG-TERM INVESTMENTS - Investment in equity                     
                securities, at fair value-Juventas Cell Therapy                  
                Ltd. (Details)                                                   
92: R63         INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND  HTML     89K 
                LONG-TERM INVESTMENTS - Investment in equity                     
                securities, at fair value-Alesta Therapeutics B.V.               
                (Details)                                                        
93: R64         INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND  HTML     78K 
                LONG-TERM INVESTMENTS - Investment in equity                     
                securities, at fair value-Cleave Therapeutics,                   
                Inc. (Details)                                                   
94: R65         INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND  HTML     75K 
                LONG-TERM INVESTMENTS - Investment in Precision                  
                Autoimmune Therapeutics Co Ltd (Pat) (Details)                   
95: R66         Inventories (Details)                               HTML     43K 
96: R67         Leases - (Details)                                  HTML     57K 
97: R68         Leases - Right of Use Assets and Liabilities        HTML     51K 
                (Details)                                                        
98: R69         LEASES - Supplemental Cash Flow (Details)           HTML     45K 
99: R70         LEASES - Future Undiscounted Cash Flows (Details)   HTML     61K 
100: R71         PROPERTY, PLANT AND EQUIPMENT - Narratives          HTML     50K  
                (Details)                                                        
101: R72         PROPERTY, PLANT AND EQUIPMENT - By type (Details)   HTML     55K  
102: R73         INTANGIBLE ASSETS - Narratives (Details)            HTML     72K  
103: R74         INTANGIBLE ASSETS - Net Definite-lived Intangible   HTML     59K  
                Assets (Details)                                                 
104: R75         INTANGIBLE ASSETS - Intangible Assets Rollforward   HTML     50K  
                (Details)                                                        
105: R76         INTANGIBLE ASSETS - Expected Future Amortization    HTML     52K  
                Expense (Details)                                                
106: R77         Accrued and Other Current Liabilities, and Other    HTML     73K  
                Liabilities (Details)                                            
107: R78         Short Term Borrowings (Details)                     HTML     63K  
108: R79         Notes Payable (Details)                             HTML     50K  
109: R80         Grants (Details)                                    HTML     51K  
110: R81         Redeemable Noncontrolling Interest and Long Term    HTML     96K  
                Borrowing (Details)                                              
111: R82         Redeemable Noncontrolling Interest and Long Term    HTML     51K  
                Borrowing - Changes in Redeemable Noncontrolling                 
                Interest (Details)                                               
112: R83         Shareholders' Equity (Details)                      HTML     83K  
113: R84         Shareholders' Equity - Warrants Activity (Details)  HTML     52K  
114: R85         Costs of Revenues (Details)                         HTML     42K  
115: R86         Net Loss Per Share (Details)                        HTML     43K  
116: R87         Net Loss Per Share - Basic and diluted net loss     HTML     70K  
                per share computation (Details)                                  
117: R88         Employee Benefit Plan (Details)                     HTML     44K  
118: R89         SHARE-BASED COMPENSATION - Compensation Expense     HTML     55K  
                (Details)                                                        
119: R90         SHARE-BASED COMPENSATION - Weighted-Average         HTML     55K  
                Assumptions (Details)                                            
120: R91         SHARE-BASED COMPENSATION - Options Outstanding      HTML     95K  
                (Details)                                                        
121: R92         SHARE-BASED COMPENSATION - Stock Option             HTML     70K  
                Outstanding (Details)                                            
122: R93         Share-Based Compensation (Details)                  HTML     86K  
123: R94         INCOME TAXES - Loss Before Income Taxes (Details)   HTML     50K  
124: R95         INCOME TAXES - Deferred Income Tax Assets And       HTML     72K  
                Liabilities (Details)                                            
125: R96         INCOME TAXES - Reconciliation Of The Provision For  HTML     65K  
                Income Taxes (Details)                                           
126: R97         INCOME TAXES - Valuation allowance (Details)        HTML     47K  
127: R98         INCOME TAXES - Gross Unrecognized Tax Benefits      HTML     45K  
                (Details)                                                        
128: R99         Income Taxes (Details)                              HTML     77K  
129: R100        FAIR VALUE MEASUREMENTS - Financial and             HTML     67K  
                Non-Financial Assets and Liabilities (Details)                   
130: R101        FAIR VALUE MEASUREMENTS - Quantitative Information  HTML     50K  
                about Level 3 Fair Value Measurements (Details)                  
131: R102        Fair Value Measurements (Details)                   HTML     62K  
132: R103        Related Party Transactions (Details)                HTML     83K  
133: R104        Commitments and Contingencies (Details)             HTML     58K  
134: R105        Restricted Net Assets (Details)                     HTML     40K  
135: R106        CONDENSED FINANCIAL INFORMATION OF REGISTRANT -     HTML    150K  
                Condensed Balance Sheets (Details)                               
136: R107        CONDENSED FINANCIAL INFORMATION OF REGISTRANT -     HTML    108K  
                Condensed Statements of Operations and                           
                Comprehensive Loss (Details)                                     
137: R108        CONDENSED FINANCIAL INFORMATION OF REGISTRANT -     HTML    108K  
                Condensed Statements of Cash Flows (Details)                     
139: XML         IDEA XML File -- Filing Summary                      XML    243K  
142: XML         XBRL Instance -- casi-20231231x20f_htm               XML   3.57M  
138: EXCEL       IDEA Workbook of Financial Report Info              XLSX    249K  
26: EX-101.CAL  XBRL Calculations -- casi-20231231_cal               XML    267K 
27: EX-101.DEF  XBRL Definitions -- casi-20231231_def                XML   1.32M 
28: EX-101.LAB  XBRL Labels -- casi-20231231_lab                     XML   1.83M 
29: EX-101.PRE  XBRL Presentations -- casi-20231231_pre              XML   1.74M 
25: EX-101.SCH  XBRL Schema -- casi-20231231                         XSD    324K 
140: JSON        XBRL Instance as JSON Data -- MetaLinks              668±  1.06M  
141: ZIP         XBRL Zipped Folder -- 0001558370-24-004190-xbrl      Zip   1.32M

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.24.1 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 282 </ContextCount>
<ElementCount> 535 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 88 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 14 </UnitCount>
<MyReports>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 00090 - Document - Document and Entity Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DocumentDocumentAndEntityInformation </Role>
<ShortName> Document and Entity Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 00100 - Statement - Consolidated Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/StatementConsolidatedBalanceSheets </Role>
<ShortName> Consolidated Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 00105 - Statement - Consolidated Balance Sheets (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/StatementConsolidatedBalanceSheetsParenthetical </Role>
<ShortName> Consolidated Balance Sheets (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss </Role>
<ShortName> Consolidated Statements of Operations and Comprehensive Loss </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 00300 - Statement - Consolidated Statements of Stockholders' Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/StatementConsolidatedStatementsOfStockholdersEquity </Role>
<ShortName> Consolidated Statements of Stockholders' Equity </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 00400 - Statement - Consolidated Statements of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/StatementConsolidatedStatementsOfCashFlows </Role>
<ShortName> Consolidated Statements of Cash Flows </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 10101 - Disclosure - DESCRIPTION OF BUSINESS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureDescriptionOfBusiness </Role>
<ShortName> DESCRIPTION OF BUSINESS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 10201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureSummaryOfSignificantAccountingPolicies </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 10301 - Disclosure - INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureInvestmentInEquitySecuritiesAtFairValueAndLongTermInvestments </Role>
<ShortName> INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 10401 - Disclosure - INVENTORIES </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureInventories </Role>
<ShortName> INVENTORIES </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 10501 - Disclosure - LEASES </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureLeases </Role>
<ShortName> LEASES </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 10601 - Disclosure - PROPERTY, PLANT AND EQUIPMENT </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosurePropertyPlantAndEquipment </Role>
<ShortName> PROPERTY, PLANT AND EQUIPMENT </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 10701 - Disclosure - INTANGIBLE ASSETS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureIntangibleAssets </Role>
<ShortName> INTANGIBLE ASSETS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 10801 - Disclosure - ACCRUED AND OTHER CURRENT LIABILITIES, AND OTHER LIABILITIES </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureAccruedAndOtherCurrentLiabilitiesAndOtherLiabilities </Role>
<ShortName> ACCRUED AND OTHER CURRENT LIABILITIES, AND OTHER LIABILITIES </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 10901 - Disclosure - SHORT TERM BORROWINGS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureShortTermBorrowings </Role>
<ShortName> SHORT TERM BORROWINGS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 11001 - Disclosure - NOTES PAYABLE </LongName>
<ReportType> Notes </ReportType>
<Role> http://www.entremed.com/role/DisclosureNotesPayable </Role>
<ShortName> NOTES PAYABLE </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 11101 - Disclosure - GRANTS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureGrants </Role>
<ShortName> GRANTS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 11201 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST AND LONG TERM BORROWING </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureRedeemableNoncontrollingInterestAndLongTermBorrowing </Role>
<ShortName> REDEEMABLE NONCONTROLLING INTEREST AND LONG TERM BORROWING </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 11301 - Disclosure - SHAREHOLDERS' EQUITY </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureShareholdersEquity </Role>
<ShortName> SHAREHOLDERS' EQUITY </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 19 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 11401 - Disclosure - COSTS OF REVENUES </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureCostsOfRevenues </Role>
<ShortName> COSTS OF REVENUES </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 20 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 11501 - Disclosure - NET LOSS PER SHARE </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureNetLossPerShare </Role>
<ShortName> NET LOSS PER SHARE </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 21 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 11601 - Disclosure - EMPLOYEE BENEFIT PLAN </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureEmployeeBenefitPlan </Role>
<ShortName> EMPLOYEE BENEFIT PLAN </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 22 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 11701 - Disclosure - SHARE-BASED COMPENSATION </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureShareBasedCompensation </Role>
<ShortName> SHARE-BASED COMPENSATION </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 23 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 11801 - Disclosure - INCOME TAXES </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureIncomeTaxes </Role>
<ShortName> INCOME TAXES </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 24 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 11901 - Disclosure - FAIR VALUE MEASUREMENTS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureFairValueMeasurements </Role>
<ShortName> FAIR VALUE MEASUREMENTS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 25 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 12001 - Disclosure - RELATED PARTY TRANSACTIONS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureRelatedPartyTransactions </Role>
<ShortName> RELATED PARTY TRANSACTIONS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 26 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 12101 - Disclosure - COMMITMENTS AND CONTINGENCIES </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureCommitmentsAndContingencies </Role>
<ShortName> COMMITMENTS AND CONTINGENCIES </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 27 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 12201 - Disclosure - RESTRICTED NET ASSETS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureRestrictedNetAssets </Role>
<ShortName> RESTRICTED NET ASSETS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 28 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 12301 - Disclosure - SUBSEQUENT EVENTS </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureSubsequentEvents </Role>
<ShortName> SUBSEQUENT EVENTS </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 29 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 12401 - Disclosure - CONDENSED FINANCIAL INFORMATION OF REGISTRANT </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureCondensedFinancialInformationOfRegistrant </Role>
<ShortName> CONDENSED FINANCIAL INFORMATION OF REGISTRANT </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 30 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 20202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<Position> 31 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 30203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureSummaryOfSignificantAccountingPolicies </ParentRole>
<Position> 32 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 30303 - Disclosure - INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureInvestmentInEquitySecuritiesAtFairValueAndLongTermInvestmentsTables </Role>
<ShortName> INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureInvestmentInEquitySecuritiesAtFairValueAndLongTermInvestments </ParentRole>
<Position> 33 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 30503 - Disclosure - LEASES (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureLeasesTables </Role>
<ShortName> LEASES (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureLeases </ParentRole>
<Position> 34 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 30603 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosurePropertyPlantAndEquipmentTables </Role>
<ShortName> PROPERTY, PLANT AND EQUIPMENT (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosurePropertyPlantAndEquipment </ParentRole>
<Position> 35 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 30703 - Disclosure - INTANGIBLE ASSETS (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureIntangibleAssetsTables </Role>
<ShortName> INTANGIBLE ASSETS (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureIntangibleAssets </ParentRole>
<Position> 36 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 30803 - Disclosure - ACCRUED AND OTHER CURRENT LIABILITIES, AND OTHER LIABILITIES (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureAccruedAndOtherCurrentLiabilitiesAndOtherLiabilitiesTables </Role>
<ShortName> ACCRUED AND OTHER CURRENT LIABILITIES, AND OTHER LIABILITIES (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureAccruedAndOtherCurrentLiabilitiesAndOtherLiabilities </ParentRole>
<Position> 37 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 31203 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureRedeemableNoncontrollingInterestTables </Role>
<ShortName> REDEEMABLE NONCONTROLLING INTEREST (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureRedeemableNoncontrollingInterestAndLongTermBorrowing </ParentRole>
<Position> 38 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 31303 - Disclosure - SHAREHOLDERS' EQUITY (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureShareholdersEquityTables </Role>
<ShortName> SHAREHOLDERS' EQUITY (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureShareholdersEquity </ParentRole>
<Position> 39 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 31503 - Disclosure - NET LOSS PER SHARE (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureNetLossPerShareTables </Role>
<ShortName> NET LOSS PER SHARE (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureNetLossPerShare </ParentRole>
<Position> 40 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 31703 - Disclosure - SHARE-BASED COMPENSATION (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureShareBasedCompensationTables </Role>
<ShortName> SHARE-BASED COMPENSATION (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureShareBasedCompensation </ParentRole>
<Position> 41 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 31803 - Disclosure - INCOME TAXES (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureIncomeTaxesTables </Role>
<ShortName> INCOME TAXES (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureIncomeTaxes </ParentRole>
<Position> 42 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 31903 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureFairValueMeasurementsTables </Role>
<ShortName> FAIR VALUE MEASUREMENTS (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureFairValueMeasurements </ParentRole>
<Position> 43 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 32401 - Disclosure - CONDENSED FINANCIAL INFORMATION OF REGISTRANT (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureCondensedFinancialInformationOfRegistrantTables </Role>
<ShortName> CONDENSED FINANCIAL INFORMATION OF REGISTRANT (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureCondensedFinancialInformationOfRegistrant </ParentRole>
<Position> 44 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 40101 - Disclosure - DESCRIPTION OF BUSINESS - Liquidity and Capital Resources (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureDescriptionOfBusinessLiquidityAndCapitalResourcesDetails </Role>
<ShortName> DESCRIPTION OF BUSINESS - Liquidity and Capital Resources (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 45 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 40102 - Disclosure - DESCRIPTION OF BUSINESS - License and Distribution Agreements (China Resources Pharmaceutical Commercial Group International Trading Co., Ltd.) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureDescriptionOfBusinessLicenseAndDistributionAgreementsChinaResourcesPharmaceuticalCommercialGroupInternationalTradingCoLtdDetails </Role>
<ShortName> DESCRIPTION OF BUSINESS - License and Distribution Agreements (China Resources Pharmaceutical Commercial Group International Trading Co., Ltd.) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 46 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R47.htm </HtmlFileName>
<LongName> 40103 - Disclosure - DESCRIPTION OF BUSINESS - License and Distribution Agreements (Precision Autoimmune Therapeutics Co., Ltd) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureDescriptionOfBusinessLicenseAndDistributionAgreementsPrecisionAutoimmuneTherapeuticsCoLtdDetails </Role>
<ShortName> DESCRIPTION OF BUSINESS - License and Distribution Agreements (Precision Autoimmune Therapeutics Co., Ltd) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 47 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R48.htm </HtmlFileName>
<LongName> 40104 - Disclosure - DESCRIPTION OF BUSINESS - License and Distribution Agreements (Juventas Cell Therapy Ltd.) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureDescriptionOfBusinessLicenseAndDistributionAgreementsJuventasCellTherapyLtdDetails </Role>
<ShortName> DESCRIPTION OF BUSINESS - License and Distribution Agreements (Juventas Cell Therapy Ltd.) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 48 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R49.htm </HtmlFileName>
<LongName> 40105 - Disclosure - DESCRIPTION OF BUSINESS - License and Distribution Agreements (BioInvent International AB) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureDescriptionOfBusinessLicenseAndDistributionAgreementsBioinventInternationalAbDetails </Role>
<ShortName> DESCRIPTION OF BUSINESS - License and Distribution Agreements (BioInvent International AB) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 49 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R50.htm </HtmlFileName>
<LongName> 40106 - Disclosure - DESCRIPTION OF BUSINESS - License and Distribution Agreements (Black Belt Therapeutics Limited) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureDescriptionOfBusinessLicenseAndDistributionAgreementsBlackBeltTherapeuticsLimitedDetails </Role>
<ShortName> DESCRIPTION OF BUSINESS - License and Distribution Agreements (Black Belt Therapeutics Limited) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 50 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R51.htm </HtmlFileName>
<LongName> 40107 - Disclosure - DESCRIPTION OF BUSINESS - License and Distribution Agreements (Cleave Therapeutics, Inc.) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureDescriptionOfBusinessLicenseAndDistributionAgreementsCleaveTherapeuticsIncDetails </Role>
<ShortName> DESCRIPTION OF BUSINESS - License and Distribution Agreements (Cleave Therapeutics, Inc.) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 51 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R52.htm </HtmlFileName>
<LongName> 40108 - Disclosure - DESCRIPTION OF BUSINESS - License and Distribution Agreements (Pharmathen Global BV) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureDescriptionOfBusinessLicenseAndDistributionAgreementsPharmathenGlobalBvDetails </Role>
<ShortName> DESCRIPTION OF BUSINESS - License and Distribution Agreements (Pharmathen Global BV) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 52 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R53.htm </HtmlFileName>
<LongName> 40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Consolidation (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureSummaryOfSignificantAccountingPoliciesConsolidationDetails </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Consolidation (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 53 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R54.htm </HtmlFileName>
<LongName> 40202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment Reporting (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureSummaryOfSignificantAccountingPoliciesSegmentReportingDetails </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Segment Reporting (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 54 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R55.htm </HtmlFileName>
<LongName> 40203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash and Cash Equivalents (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureSummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash and Cash Equivalents (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 55 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R56.htm </HtmlFileName>
<LongName> 40204 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Aggregate Cost And Fair Value (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureSummaryOfSignificantAccountingPoliciesAggregateCostAndFairValueDetails </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Aggregate Cost And Fair Value (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 56 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R57.htm </HtmlFileName>
<LongName> 40205 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - PPE (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPpeDetails </Role>
<ShortName> SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - PPE (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables </ParentRole>
<Position> 57 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R58.htm </HtmlFileName>
<LongName> 40301 - Disclosure - INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - Investment in equity securities, at fair value-MaxCyte Inc. (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureInvestmentInEquitySecuritiesAtFairValueAndLongTermInvestmentsInvestmentInEquitySecuritiesAtFairValueMaxcyteIncDetails </Role>
<ShortName> INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - Investment in equity securities, at fair value-MaxCyte Inc. (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 58 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R59.htm </HtmlFileName>
<LongName> 40302 - Disclosure - INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - Investment in equity securities, at fair value-BioInvent International AB ordinary shares and warrants (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureInvestmentInEquitySecuritiesAtFairValueAndLongTermInvestmentsInvestmentInEquitySecuritiesAtFairValueBioinventInternationalAbOrdinarySharesAndWarrantsDetails </Role>
<ShortName> INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - Investment in equity securities, at fair value-BioInvent International AB ordinary shares and warrants (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 59 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R60.htm </HtmlFileName>
<LongName> 40303 - Disclosure - INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - BioInvent International AB - Summary of Investments (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureInvestmentInEquitySecuritiesAtFairValueAndLongTermInvestmentsBioinventInternationalAbSummaryOfInvestmentsDetails </Role>
<ShortName> INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - BioInvent International AB - Summary of Investments (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 60 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R61.htm </HtmlFileName>
<LongName> 40304 - Disclosure - INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - Summary of Long-term investments (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureInvestmentInEquitySecuritiesAtFairValueAndLongTermInvestmentsSummaryOfLongTermInvestmentsDetails </Role>
<ShortName> INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - Summary of Long-term investments (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 61 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R62.htm </HtmlFileName>
<LongName> 40305 - Disclosure - INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - Investment in equity securities, at fair value-Juventas Cell Therapy Ltd. (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureInvestmentInEquitySecuritiesAtFairValueAndLongTermInvestmentsInvestmentInEquitySecuritiesAtFairValueJuventasCellTherapyLtdDetails </Role>
<ShortName> INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - Investment in equity securities, at fair value-Juventas Cell Therapy Ltd. (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 62 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R63.htm </HtmlFileName>
<LongName> 40306 - Disclosure - INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - Investment in equity securities, at fair value-Alesta Therapeutics B.V. (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureInvestmentInEquitySecuritiesAtFairValueAndLongTermInvestmentsInvestmentInEquitySecuritiesAtFairValueAlestaTherapeuticsBvDetails </Role>
<ShortName> INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - Investment in equity securities, at fair value-Alesta Therapeutics B.V. (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 63 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R64.htm </HtmlFileName>
<LongName> 40307 - Disclosure - INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - Investment in equity securities, at fair value-Cleave Therapeutics, Inc. (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureInvestmentInEquitySecuritiesAtFairValueAndLongTermInvestmentsInvestmentInEquitySecuritiesAtFairValueCleaveTherapeuticsIncDetails </Role>
<ShortName> INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - Investment in equity securities, at fair value-Cleave Therapeutics, Inc. (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 64 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R65.htm </HtmlFileName>
<LongName> 40308 - Disclosure - INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - Investment in Precision Autoimmune Therapeutics Co Ltd (PAT) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureInvestmentInEquitySecuritiesAtFairValueAndLongTermInvestmentsInvestmentInPrecisionAutoimmuneTherapeuticsCoLtdPatDetails </Role>
<ShortName> INVESTMENT IN EQUITY SECURITIES, AT FAIR VALUE AND LONG-TERM INVESTMENTS - Investment in Precision Autoimmune Therapeutics Co Ltd (PAT) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 65 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R66.htm </HtmlFileName>
<LongName> 40401 - Disclosure - INVENTORIES (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureInventoriesDetails </Role>
<ShortName> INVENTORIES (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureInventories </ParentRole>
<Position> 66 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R67.htm </HtmlFileName>
<LongName> 40501 - Disclosure - LEASES - (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureLeasesDetails </Role>
<ShortName> LEASES - (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 67 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R68.htm </HtmlFileName>
<LongName> 40502 - Disclosure - LEASES - Right of Use Assets and Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureLeasesRightOfUseAssetsAndLiabilitiesDetails </Role>
<ShortName> LEASES - Right of Use Assets and Liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 68 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R69.htm </HtmlFileName>
<LongName> 40503 - Disclosure - LEASES - Supplemental Cash Flow (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureLeasesSupplementalCashFlowDetails </Role>
<ShortName> LEASES - Supplemental Cash Flow (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 69 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R70.htm </HtmlFileName>
<LongName> 40504 - Disclosure - LEASES - Future Undiscounted Cash Flows (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureLeasesFutureUndiscountedCashFlowsDetails </Role>
<ShortName> LEASES - Future Undiscounted Cash Flows (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 70 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R71.htm </HtmlFileName>
<LongName> 40601 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - Narratives (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosurePropertyPlantAndEquipmentNarrativesDetails </Role>
<ShortName> PROPERTY, PLANT AND EQUIPMENT - Narratives (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 71 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R72.htm </HtmlFileName>
<LongName> 40602 - Disclosure - PROPERTY, PLANT AND EQUIPMENT - By type (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosurePropertyPlantAndEquipmentByTypeDetails </Role>
<ShortName> PROPERTY, PLANT AND EQUIPMENT - By type (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 72 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R73.htm </HtmlFileName>
<LongName> 40701 - Disclosure - INTANGIBLE ASSETS - Narratives (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureIntangibleAssetsNarrativesDetails </Role>
<ShortName> INTANGIBLE ASSETS - Narratives (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 73 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R74.htm </HtmlFileName>
<LongName> 40702 - Disclosure - INTANGIBLE ASSETS - Net Definite-lived Intangible Assets (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureIntangibleAssetsNetDefiniteLivedIntangibleAssetsDetails </Role>
<ShortName> INTANGIBLE ASSETS - Net Definite-lived Intangible Assets (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 74 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R75.htm </HtmlFileName>
<LongName> 40703 - Disclosure - INTANGIBLE ASSETS - Intangible Assets Rollforward (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureIntangibleAssetsIntangibleAssetsRollforwardDetails </Role>
<ShortName> INTANGIBLE ASSETS - Intangible Assets Rollforward (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 75 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R76.htm </HtmlFileName>
<LongName> 40704 - Disclosure - INTANGIBLE ASSETS - Expected Future Amortization Expense (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureIntangibleAssetsExpectedFutureAmortizationExpenseDetails </Role>
<ShortName> INTANGIBLE ASSETS - Expected Future Amortization Expense (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 76 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R77.htm </HtmlFileName>
<LongName> 40801 - Disclosure - ACCRUED AND OTHER CURRENT LIABILITIES, AND OTHER LIABILITIES (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureAccruedAndOtherCurrentLiabilitiesAndOtherLiabilitiesDetails </Role>
<ShortName> ACCRUED AND OTHER CURRENT LIABILITIES, AND OTHER LIABILITIES (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureAccruedAndOtherCurrentLiabilitiesAndOtherLiabilitiesTables </ParentRole>
<Position> 77 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R78.htm </HtmlFileName>
<LongName> 40901 - Disclosure - SHORT TERM BORROWINGS (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureShortTermBorrowingsDetails </Role>
<ShortName> SHORT TERM BORROWINGS (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureShortTermBorrowings </ParentRole>
<Position> 78 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R79.htm </HtmlFileName>
<LongName> 41001 - Disclosure - NOTES PAYABLE (Details) </LongName>
<ReportType> Notes </ReportType>
<Role> http://www.entremed.com/role/DisclosureNotesPayableDetails </Role>
<ShortName> NOTES PAYABLE (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureNotesPayable </ParentRole>
<Position> 79 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R80.htm </HtmlFileName>
<LongName> 41101 - Disclosure - GRANTS (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureGrantsDetails </Role>
<ShortName> GRANTS (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureGrants </ParentRole>
<Position> 80 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R81.htm </HtmlFileName>
<LongName> 41201 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST AND LONG TERM BORROWING (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureRedeemableNoncontrollingInterestAndLongTermBorrowingDetails </Role>
<ShortName> REDEEMABLE NONCONTROLLING INTEREST AND LONG TERM BORROWING (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureRedeemableNoncontrollingInterestAndLongTermBorrowing </ParentRole>
<Position> 81 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R82.htm </HtmlFileName>
<LongName> 41202 - Disclosure - REDEEMABLE NONCONTROLLING INTEREST AND LONG TERM BORROWING - Changes in Redeemable Noncontrolling Interest (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureRedeemableNoncontrollingInterestAndLongTermBorrowingChangesInRedeemableNoncontrollingInterestDetails </Role>
<ShortName> REDEEMABLE NONCONTROLLING INTEREST AND LONG TERM BORROWING - Changes in Redeemable Noncontrolling Interest (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 82 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R83.htm </HtmlFileName>
<LongName> 41301 - Disclosure - SHAREHOLDERS' EQUITY (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureShareholdersEquityDetails </Role>
<ShortName> SHAREHOLDERS' EQUITY (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureShareholdersEquityTables </ParentRole>
<Position> 83 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R84.htm </HtmlFileName>
<LongName> 41302 - Disclosure - SHAREHOLDERS' EQUITY - Warrants Activity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureShareholdersEquityWarrantsActivityDetails </Role>
<ShortName> SHAREHOLDERS' EQUITY - Warrants Activity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 84 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R85.htm </HtmlFileName>
<LongName> 41401 - Disclosure - COSTS OF REVENUES (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureCostsOfRevenuesDetails </Role>
<ShortName> COSTS OF REVENUES (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureCostsOfRevenues </ParentRole>
<Position> 85 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R86.htm </HtmlFileName>
<LongName> 41501 - Disclosure - NET LOSS PER SHARE (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureNetLossPerShareDetails </Role>
<ShortName> NET LOSS PER SHARE (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureNetLossPerShareTables </ParentRole>
<Position> 86 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R87.htm </HtmlFileName>
<LongName> 41502 - Disclosure - NET LOSS PER SHARE - Basic and diluted net loss per share computation (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureNetLossPerShareBasicAndDilutedNetLossPerShareComputationDetails </Role>
<ShortName> NET LOSS PER SHARE - Basic and diluted net loss per share computation (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 87 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R88.htm </HtmlFileName>
<LongName> 41601 - Disclosure - EMPLOYEE BENEFIT PLAN (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureEmployeeBenefitPlanDetails </Role>
<ShortName> EMPLOYEE BENEFIT PLAN (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureEmployeeBenefitPlan </ParentRole>
<Position> 88 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R89.htm </HtmlFileName>
<LongName> 41701 - Disclosure - SHARE-BASED COMPENSATION - Compensation Expense (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureShareBasedCompensationCompensationExpenseDetails </Role>
<ShortName> SHARE-BASED COMPENSATION - Compensation Expense (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 89 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R90.htm </HtmlFileName>
<LongName> 41702 - Disclosure - SHARE-BASED COMPENSATION - Weighted-Average Assumptions (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureShareBasedCompensationWeightedAverageAssumptionsDetails </Role>
<ShortName> SHARE-BASED COMPENSATION - Weighted-Average Assumptions (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 90 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R91.htm </HtmlFileName>
<LongName> 41703 - Disclosure - SHARE-BASED COMPENSATION - Options Outstanding (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureShareBasedCompensationOptionsOutstandingDetails </Role>
<ShortName> SHARE-BASED COMPENSATION - Options Outstanding (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 91 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R92.htm </HtmlFileName>
<LongName> 41704 - Disclosure - SHARE-BASED COMPENSATION - Stock Option Outstanding (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureShareBasedCompensationStockOptionOutstandingDetails </Role>
<ShortName> SHARE-BASED COMPENSATION - Stock Option Outstanding (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 92 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R93.htm </HtmlFileName>
<LongName> 41705 - Disclosure - SHARE-BASED COMPENSATION (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureShareBasedCompensationDetails </Role>
<ShortName> SHARE-BASED COMPENSATION (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureShareBasedCompensationTables </ParentRole>
<Position> 93 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R94.htm </HtmlFileName>
<LongName> 41801 - Disclosure - INCOME TAXES - Loss Before Income Taxes (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureIncomeTaxesLossBeforeIncomeTaxesDetails </Role>
<ShortName> INCOME TAXES - Loss Before Income Taxes (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 94 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R95.htm </HtmlFileName>
<LongName> 41802 - Disclosure - INCOME TAXES - Deferred Income Tax Assets And Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureIncomeTaxesDeferredIncomeTaxAssetsAndLiabilitiesDetails </Role>
<ShortName> INCOME TAXES - Deferred Income Tax Assets And Liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 95 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R96.htm </HtmlFileName>
<LongName> 41803 - Disclosure - INCOME TAXES - Reconciliation Of The Provision For Income Taxes (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureIncomeTaxesReconciliationOfProvisionForIncomeTaxesDetails </Role>
<ShortName> INCOME TAXES - Reconciliation Of The Provision For Income Taxes (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 96 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R97.htm </HtmlFileName>
<LongName> 41804 - Disclosure - INCOME TAXES - Valuation allowance (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureIncomeTaxesValuationAllowanceDetails </Role>
<ShortName> INCOME TAXES - Valuation allowance (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 97 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R98.htm </HtmlFileName>
<LongName> 41805 - Disclosure - INCOME TAXES - Gross Unrecognized Tax Benefits (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureIncomeTaxesGrossUnrecognizedTaxBenefitsDetails </Role>
<ShortName> INCOME TAXES - Gross Unrecognized Tax Benefits (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 98 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R99.htm </HtmlFileName>
<LongName> 41806 - Disclosure - INCOME TAXES (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureIncomeTaxesDetails </Role>
<ShortName> INCOME TAXES (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureIncomeTaxesTables </ParentRole>
<Position> 99 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R100.htm </HtmlFileName>
<LongName> 41901 - Disclosure - FAIR VALUE MEASUREMENTS - Financial and Non-Financial Assets and Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureFairValueMeasurementsFinancialAndNonFinancialAssetsAndLiabilitiesDetails </Role>
<ShortName> FAIR VALUE MEASUREMENTS - Financial and Non-Financial Assets and Liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 100 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R101.htm </HtmlFileName>
<LongName> 41902 - Disclosure - FAIR VALUE MEASUREMENTS - Quantitative Information about Level 3 Fair Value Measurements (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureFairValueMeasurementsQuantitativeInformationAboutLevel3FairValueMeasurementsDetails </Role>
<ShortName> FAIR VALUE MEASUREMENTS - Quantitative Information about Level 3 Fair Value Measurements (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 101 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R102.htm </HtmlFileName>
<LongName> 41903 - Disclosure - FAIR VALUE MEASUREMENTS (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureFairValueMeasurementsDetails </Role>
<ShortName> FAIR VALUE MEASUREMENTS (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureFairValueMeasurementsTables </ParentRole>
<Position> 102 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R103.htm </HtmlFileName>
<LongName> 42001 - Disclosure - RELATED PARTY TRANSACTIONS (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureRelatedPartyTransactionsDetails </Role>
<ShortName> RELATED PARTY TRANSACTIONS (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureRelatedPartyTransactions </ParentRole>
<Position> 103 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R104.htm </HtmlFileName>
<LongName> 42101 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureCommitmentsAndContingenciesDetails </Role>
<ShortName> COMMITMENTS AND CONTINGENCIES (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureCommitmentsAndContingencies </ParentRole>
<Position> 104 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R105.htm </HtmlFileName>
<LongName> 42201 - Disclosure - RESTRICTED NET ASSETS (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureRestrictedNetAssetsDetails </Role>
<ShortName> RESTRICTED NET ASSETS (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.entremed.com/role/DisclosureRestrictedNetAssets </ParentRole>
<Position> 105 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R106.htm </HtmlFileName>
<LongName> 42401 - Disclosure - CONDENSED FINANCIAL INFORMATION OF REGISTRANT - Condensed Balance Sheets (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureCondensedFinancialInformationOfRegistrantCondensedBalanceSheetsDetails </Role>
<ShortName> CONDENSED FINANCIAL INFORMATION OF REGISTRANT - Condensed Balance Sheets (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 106 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R107.htm </HtmlFileName>
<LongName> 42402 - Disclosure - CONDENSED FINANCIAL INFORMATION OF REGISTRANT - Condensed Statements of Operations and Comprehensive Loss (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureCondensedFinancialInformationOfRegistrantCondensedStatementsOfOperationsAndComprehensiveLossDetails </Role>
<ShortName> CONDENSED FINANCIAL INFORMATION OF REGISTRANT - Condensed Statements of Operations and Comprehensive Loss (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 107 </Position>
</Report>
<Report instance="casi-20231231x20f.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R108.htm </HtmlFileName>
<LongName> 42403 - Disclosure - CONDENSED FINANCIAL INFORMATION OF REGISTRANT - Condensed Statements of Cash Flows (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.entremed.com/role/DisclosureCondensedFinancialInformationOfRegistrantCondensedStatementsOfCashFlowsDetails </Role>
<ShortName> CONDENSED FINANCIAL INFORMATION OF REGISTRANT - Condensed Statements of Cash Flows (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 108 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<Logs>
<Log type="Warning"> [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: casi:PercentageOfInterestInBoardSeats, casi:ReductionInRegisteredCapital, us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate - casi-20231231x20f.htm 9 </Log>
<Log type="Warning"> [ix-0514-Hidden-Fact-Not-Referenced] WARN: 10 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: casi:ShareBasedPaymentCashReceivedFromStockOptionExercises, us-gaap:CommitmentsAndContingencies, us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList, us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList, us-gaap:OtherReceivableAfterAllowanceForCreditLossRelatedPartyTypeExtensibleEnumeration, us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOffStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration - casi-20231231x20f.htm 9 </Log>
</Logs>
<InputFiles>
<File> casi-20231231.xsd </File>
<File> casi-20231231_cal.xml </File>
<File> casi-20231231_def.xml </File>
<File> casi-20231231_lab.xml </File>
<File> casi-20231231_pre.xml </File>
<File doctype="20-F" isDefinitelyFs="true" isUsgaap="true" original="casi-20231231x20f.htm"> casi-20231231x20f.htm </File>
</InputFiles>
<SupplementalFiles>
<File> casi-20231231x20f009.jpg </File>
<File> casi-20231231x20f010.jpg </File>
<File> casi-20231231x20f011.jpg </File>
</SupplementalFiles>
<BaseTaxonomies>
<BaseTaxonomy items="3"> http://fasb.org/srt/2023 </BaseTaxonomy>
<BaseTaxonomy items="1079"> http://fasb.org/us-gaap/2023 </BaseTaxonomy>
<BaseTaxonomy items="46"> http://xbrl.sec.gov/dei/2023 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

14 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/23/23  CASI Pharmaceuticals, Inc.        S-8 POS     5/23/23    3:156K                                   Toppan Merrill/FA
 4/26/23  CASI Pharmaceuticals, Inc.        20-F       12/31/22  129:16M                                    Toppan Merrill Bridge/FA
 1/31/23  CASI Pharmaceuticals, Inc.        F-4                   22:2.7M                                   Toppan Merrill/FA
11/14/22  CASI Pharmaceuticals, Inc. (DE)   10-Q        9/30/22   74:7.2M                                   Toppan Merrill Bridge/FA
 8/12/22  CASI Pharmaceuticals, Inc. (DE)   10-Q        6/30/22   76:8.1M                                   Toppan Merrill Bridge/FA
12/10/21  CASI Pharmaceuticals, Inc. (DE)   8-K:5,9    12/08/21   12:219K                                   Toppan Merrill/FA
 3/30/21  CASI Pharmaceuticals, Inc. (DE)   10-K       12/31/20  109:13M                                    Toppan Merrill Bridge/FA
11/09/20  CASI Pharmaceuticals, Inc. (DE)   10-Q        9/30/20   91:7.2M                                   Toppan Merrill/FA
 3/16/20  CASI Pharmaceuticals, Inc. (DE)   10-K       12/31/19   98:6.9M                                   Toppan Merrill/FA
 8/09/19  CASI Pharmaceuticals, Inc. (DE)   10-Q        6/30/19   75:16M                                    Toppan Merrill/FA
 5/15/19  CASI Pharmaceuticals, Inc. (DE)   10-Q        3/31/19   78:5.6M                                   Toppan Merrill/FA
 3/29/19  CASI Pharmaceuticals, Inc. (DE)   10-K       12/31/18   91:7.7M                                   Toppan Merrill/FA
 8/14/17  CASI Pharmaceuticals, Inc. (DE)   10-Q        6/30/17   40:1.7M                                   Toppan Merrill/FA
 4/17/07  CASI Pharmaceuticals, Inc.        8-K:5,8,9   4/16/07    9:152K                                   Bowne - DC/FA
↑Top
Filing Submission 0001558370-24-004190   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Sun., Apr. 28, 1:20:37.2am ET